2021, Number 1
<< Back
Rev cubana med 2021; 60 (1)
Cuban miracle?
Blanco AMÁ
Language: Spanish
References: 4
Page: 1-3
PDF size: 197.43 Kb.
Text Extraction
No abstract.
REFERENCES
Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert JHHM, Bonten MJM.Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study.Lancet Public Health. 2020[11/12/2020];5:e452–9.https://www.medrxiv.org/content/10.1101/2020.05.29.20109199v1
Pereda R, González D, Rivero HB, Rivero JC, Pérez A, López LR, et al. Therapeutic effectivenessof interferon- alpha2b against COVID-19: the Cuban experience. MedRxiv. 2020.https://doi.org/10.1101/2020.05.29.20109199
Saavedra D, Añé-Kourí AL, Sánchez N, Filgueira LM, Betancourt J, Herrera C, et al. An anti-CD6monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.Immun Ageing. 2020. https://doi.org/10.1186/s12979-020-00207-8
Venegas R, Santana R, Peña R, Bequet M, Hernández M, Santiesteban B, et al. CIGB-258immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19patients. MedRxiv. 2020[11/12/2020].https://www.medrxiv.org/content/10.1101/2020.05.27.20110601v1.full.pdf